Does Use of the Voy Program Improve Weight Loss Percentage and Other Health Outcomes in a Population Already Taking GLP/GIP-1RA Medication?
NCT06710587
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
470
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Weight Loss
Interventions
BEHAVIORAL:
Voy Program
Sponsor
Menwell Limited
Collaborators
[object Object]